SG11201607149WA - Method for identifying a biomarker indicative of a reduced drug response using a thermal shift assay - Google Patents

Method for identifying a biomarker indicative of a reduced drug response using a thermal shift assay

Info

Publication number
SG11201607149WA
SG11201607149WA SG11201607149WA SG11201607149WA SG11201607149WA SG 11201607149W A SG11201607149W A SG 11201607149WA SG 11201607149W A SG11201607149W A SG 11201607149WA SG 11201607149W A SG11201607149W A SG 11201607149WA SG 11201607149W A SG11201607149W A SG 11201607149WA
Authority
SG
Singapore
Prior art keywords
identifying
drug response
shift assay
thermal shift
reduced drug
Prior art date
Application number
SG11201607149WA
Other languages
English (en)
Inventor
Molina Daniel Martinez
Par Nordlund
Original Assignee
Pelago Bioscience AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pelago Bioscience AB filed Critical Pelago Bioscience AB
Publication of SG11201607149WA publication Critical patent/SG11201607149WA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
SG11201607149WA 2014-03-25 2015-03-25 Method for identifying a biomarker indicative of a reduced drug response using a thermal shift assay SG11201607149WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1405327.6A GB2524519B (en) 2014-03-25 2014-03-25 Methods for identifying a biomarker indicative of a reduced drug response using a thermal shift assay
PCT/GB2015/050895 WO2015145151A1 (en) 2014-03-25 2015-03-25 Method for identifying a biomarker indicative of a reduced drug response using a thermal shift assay

Publications (1)

Publication Number Publication Date
SG11201607149WA true SG11201607149WA (en) 2016-10-28

Family

ID=50686878

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201607149WA SG11201607149WA (en) 2014-03-25 2015-03-25 Method for identifying a biomarker indicative of a reduced drug response using a thermal shift assay

Country Status (10)

Country Link
US (1) US11480578B2 (ja)
EP (1) EP3123175B1 (ja)
JP (1) JP6645981B2 (ja)
CN (1) CN106233144B (ja)
CA (1) CA2942605C (ja)
DK (1) DK3123175T3 (ja)
ES (1) ES2792680T3 (ja)
GB (1) GB2524519B (ja)
SG (1) SG11201607149WA (ja)
WO (1) WO2015145151A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2524519B (en) 2014-03-25 2019-11-06 Pelago Bioscience AB Methods for identifying a biomarker indicative of a reduced drug response using a thermal shift assay
KR101862198B1 (ko) * 2016-09-30 2018-05-30 (주)스파크바이오파마 2차원 겔 전기영동에서의 열 안정성 변화-기반 형광 차이를 이용한 표적 단백질의 규명 방법
CN110291403B (zh) * 2016-12-20 2022-09-16 特里特福尔莱弗公司 通过质谱法测定braf突变和野生型braf蛋白的方法
US11630110B2 (en) 2017-08-18 2023-04-18 Agency For Science, Technology And Research Methods to identify protein interaction
CN113160878B (zh) * 2021-04-16 2022-06-10 西北工业大学 一种天然药物分子靶标蛋白的冷启动筛选方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9525481D0 (en) * 1995-12-13 1996-02-14 Royston M C Novel method
AU741049B2 (en) * 1996-05-09 2001-11-22 Life Technologies Corporation Microplate thermal shift assay and apparatus for ligand development and multi-variable protein chemistry optimization
NZ504483A (en) * 1997-11-12 2002-11-26 Dimensional Pharm Inc High throughput method for functionally classifying proteins by contacting the protein with different molecules and determining the effect on the proteins stability
US7294472B2 (en) * 2001-03-14 2007-11-13 Caden Biosciences Method for identifying modulators of G protein coupled receptor signaling
US7537891B2 (en) * 2002-08-27 2009-05-26 Bristol-Myers Squibb Company Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
JP2006515742A (ja) * 2002-08-27 2006-06-08 ブリストル−マイヤーズ スクイブ カンパニー 乳癌細胞でのプロテインチロシンキナーゼおよび/またはプロテインチロシンキナーゼ経路と相互作用および/またはモデュレートする化合物の活性を予測するためのポリヌクレオチドの同定
US20060019284A1 (en) * 2004-06-30 2006-01-26 Fei Huang Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in lung cancer cells
EP1963862A4 (en) * 2005-12-05 2010-03-03 Merck & Co Inc METHODS FOR PREDICTING REACTION TO TREATMENT FROM EXPRESSION PROFILES OF PROTEIN AND TRANSCRIPTIONAL BIOMARKERS
GB0606096D0 (en) * 2006-03-27 2006-05-03 Cbmm Sa Screening method
US20080096208A1 (en) * 2006-09-06 2008-04-24 Connors Richard W Biomarkers for assessing response to c-met treatment
EP1918714A1 (en) * 2006-11-02 2008-05-07 Koninklijke Philips Electronics N.V. Compounds and methods for double labelling of polypeptides to allow multiplexing in mass spectrometric analysis
US8476081B2 (en) * 2009-09-21 2013-07-02 Janssen Pharmaceutica Nv Assay for evaluating affinity and specificity of ligand-albumin binding
JP5819307B2 (ja) * 2009-10-20 2015-11-24 ネステク ソシエテ アノニム 発癌性融合タンパク質を検出するための近接媒介性アッセイ
US20140004530A1 (en) * 2010-12-22 2014-01-02 Cellzome Gmbh Method for the evaluation of compound-target interactions across species
US20120194522A1 (en) * 2011-02-01 2012-08-02 Life Technologies Corporation Systems and Methods for the Analysis of Protein Melt Curve Data
US9523693B2 (en) * 2011-04-18 2016-12-20 Biotarget Engagement Interest Group Ab Methods for determining ligand binding to a target protein using a thermal shift assay
GB201106548D0 (en) 2011-04-18 2011-06-01 Evitraproteoma Ab A method for determining ligand binding to a target protein using a thermal shift assahy
US9261497B2 (en) * 2012-10-16 2016-02-16 New York University Method of treating cancer with modulators of SCFSkp2
GB2524519B (en) 2014-03-25 2019-11-06 Pelago Bioscience AB Methods for identifying a biomarker indicative of a reduced drug response using a thermal shift assay

Also Published As

Publication number Publication date
US20180172697A1 (en) 2018-06-21
CN106233144B (zh) 2019-06-21
DK3123175T3 (da) 2020-05-25
JP6645981B2 (ja) 2020-02-14
CA2942605A1 (en) 2015-10-01
GB2524519B (en) 2019-11-06
ES2792680T3 (es) 2020-11-11
EP3123175B1 (en) 2020-04-22
CA2942605C (en) 2023-08-22
CN106233144A (zh) 2016-12-14
GB2524519A (en) 2015-09-30
WO2015145151A1 (en) 2015-10-01
EP3123175A1 (en) 2017-02-01
JP2017508983A (ja) 2017-03-30
US11480578B2 (en) 2022-10-25
GB201405327D0 (en) 2014-05-07

Similar Documents

Publication Publication Date Title
IL249983B (en) A method for detecting a genetic variable
HK1250045A1 (zh) 用於檢測抗cd3同二聚體的基於細胞的測定
GB2522781B (en) Mark detecting method
HK1209303A1 (en) Analyte sensing system
FI3198035T3 (fi) Menetelmiä lääkevasteen ennustamiseksi
PT3201361T (pt) Métodos de quantificação de adn acelular
GB201412977D0 (en) Single nucleotide detection method
IL246889A0 (en) A method for measuring engagement
SG10201500862RA (en) A Method for Detecting a Target Analyte
DK3128902T3 (da) Sensor til kontinuerlig analytovervågning
GB201415761D0 (en) Methods for detection of Nucleotide modification
SG11201607149WA (en) Method for identifying a biomarker indicative of a reduced drug response using a thermal shift assay
SG11201608244TA (en) Biomarkers for assessing hiv
GB201611652D0 (en) Method of detecting a condition
SG11201701046RA (en) A test strip for paper-based assay
EP3217173A4 (en) Method for detecting disease
GB201508832D0 (en) A method for detecting an analyte
ZA201708254B (en) Biomarkers for detection of tuberculosis risk
HUE051239T2 (hu) Eljárás épület hõdiagnosztikájának meghatározására
PL3136822T3 (pl) Sposób określania temperatury
HK1210267A1 (en) Method for the measurement of a measurement object by means of -ray fluorescence
IL232895A0 (en) A method for receiving effective training for the purpose of obtaining required information
IL252751A0 (en) Tests for btk inhibitors
HUE065422T2 (hu) Eljárás tûzálló alkotórész nem-destruktív vizsgálatára
GB201510216D0 (en) Methods for providing a prognosis of pregnancy